[Benign prostatic hyperplasia--choice of therapy in the elderly]

Area of Science:

• Urology
• Geriatric Medicine
• Medical Technology

Context:

• High incidence of benign prostatic hyperplasia (BPH) in elderly men necessitates effective treatments.
• Transurethral resection of the prostate (TUR-P) is the established standard, offering high success rates with low risks.
• The prevalence of BPH in men over 80 underscores the need for therapeutic advancements.

Purpose:

• To explore alternative treatments for benign prostatic hyperplasia (BPH).
• To evaluate the efficacy of minimally invasive therapies compared to traditional surgical interventions.
• To identify viable treatment options for patients with high surgical risk.

Summary:

• Transurethral resection of the prostate (TUR-P) remains the gold standard for benign prostatic hyperplasia (BPH) treatment, achieving significant symptom improvement.
• Despite extensive research, alternative medical and interventional therapies have not replicated the therapeutic efficacy of TUR-P.
• Non-surgical options are considered practical alternatives for patients who are poor surgical candidates.

Impact:

• Highlights the limitations of current minimally invasive BPH treatments.
• Emphasizes the continued importance of TUR-P in managing benign prostatic hyperplasia.
• Suggests a need for further research into more effective, less invasive BPH therapies for specific patient groups.